Professor Alasdair Coles (Chief Investigator), University of Cambridge
Professor Belinda Lennox (Principal investigator, Oxford ) University of Oxford
Professor Peter Jones, University of Cambridge
Professor Eileen Joyce, (Co-investigator) UCL University, London
Dr Michael Zandi (Principal Investigator, UCL Hospitals NHS Trust) London
Professor Ly-Mee Yu, University of Oxford
Dr Ksenija Yeeles, Project Manager, University of Oxford
Dr Francis Dowling, Senior Trial Coordinator, Cambridge Clinical Trial Unit
Dr Daniella Lawson, Trial Coordinator, Cambridge Clinical Trial Unit
SINAPPS2 team
Trial research team
Trial management group
Principal Investigators
Dr Timothy Harrower, Royal Devon & Exeter Wonford Hospital, Exeter
Dr Akram Hosseini, Queen's Medical Centre, Nottingham
Dr Ester Coutinho, King's College Hospital, London
Dr Nazar Sharaf, Salford Royal Hospital, Salford
Dr Priya Shanmugarajah, Royal Hallamshire Hospital, Sheffield
Researchers
SINAPPS stands for Study of Immunology in Antibody Positive Psychosis.
We are a research group formed of collaborating Universities in the UK, investigating the role of immunotherapy and autoimmune antibodies as a cause of psychosis.
About SINAPPS Group
